tiprankstipranks
NervGen Pharma (NGEN)
NASDAQ:NGEN
US Market
NGEN
NervGen Pharma
RESEARCH TOOLSreports
Want to see NGEN full AI Analyst Report?

NervGen Pharma (NGEN) Financial Statements

93 Followers

NervGen Pharma Financial Overview

NervGen Pharma's market cap is currently $168.34M. The company's EPS TTM is $-0.3659; its P/E ratio is -44.21; NervGen Pharma is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ 0.00C$ -58.23KC$ -109.40KC$ -84.92KC$ -33.70K
Operating IncomeC$ -25.08MC$ -17.33MC$ -13.41MC$ -16.99MC$ -10.13M
EBITDAC$ -5.65MC$ -16.62MC$ -16.78MC$ -14.82MC$ -10.03M
Net IncomeC$ -44.12MC$ -16.68MC$ -16.89MC$ -15.29MC$ -10.06M
Balance Sheet
Cash & Short-Term InvestmentsC$ 22.07MC$ 12.07MC$ 8.80MC$ 16.56MC$ 13.38M
Total AssetsC$ 23.21MC$ 13.54MC$ 9.99MC$ 17.61MC$ 14.15M
Total DebtC$ 8.37KC$ 73.38KC$ 148.78KC$ 209.10KC$ 0.00
Net DebtC$ -22.06MC$ -11.93MC$ -8.65MC$ -16.35MC$ -13.38M
Total LiabilitiesC$ 19.73MC$ 11.75MC$ 11.50MC$ 7.68MC$ 852.33K
Stockholders' EquityC$ 3.48MC$ 1.79MC$ -1.52MC$ 9.93MC$ 13.30M
Cash Flow
Free Cash FlowC$ -19.50MC$ -11.70MC$ -8.53MC$ -13.13MC$ -6.54M
Operating Cash FlowC$ -19.50MC$ -11.70MC$ -8.52MC$ -13.12MC$ -6.54M
Investing Cash FlowC$ 100.93KC$ 40.91KC$ -104.77KC$ -15.57KC$ -35.64K
Financing Cash FlowC$ 23.76MC$ 15.77MC$ 578.16KC$ 16.70MC$ 15.51M
Currency in CAD

NervGen Pharma Earnings and Revenue History

Income Statement >

NervGen Pharma Debt to Assets

Balance Sheet >

NervGen Pharma Cash Flow

Cash Flow >

NervGen Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >